Segui
Holly M. Mortensen
Holly M. Mortensen
Email verificata su epa.gov
Titolo
Citata da
Citata da
Anno
Convergent adaptation of human lactase persistence in Africa and Europe
SA Tishkoff, FA Reed, A Ranciaro, BF Voight, CC Babbitt, JS Silverman, ...
Nature genetics 39 (1), 31-40, 2007
18262007
The genetic structure and history of Africans and African Americans
SA Tishkoff, FA Reed, FR Friedlaender, C Ehret, A Ranciaro, A Froment, ...
science 324 (5930), 1035-1044, 2009
17932009
In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project
RS Judson, KA Houck, RJ Kavlock, TB Knudsen, MT Martin, ...
Environmental health perspectives 118 (4), 485-492, 2010
5882010
Whole-mtDNA genome sequence analysis of ancient African lineages
MK Gonder, HM Mortensen, FA Reed, A de Sousa, SA Tishkoff
Molecular biology and evolution 24 (3), 757-768, 2007
3722007
History of click-speaking populations of Africa inferred from mtDNA and Y chromosome genetic variation
SA Tishkoff, MK Gonder, BM Henn, H Mortensen, A Knight, C Gignoux, ...
Molecular biology and evolution 24 (10), 2180-2195, 2007
2962007
African Y chromosome and mtDNA divergence provides insight into the history of click languages
A Knight, PA Underhill, HM Mortensen, LA Zhivotovsky, AA Lin, BM Henn, ...
Current Biology 13 (6), 464-473, 2003
2422003
Native American mtDNA prehistory in the American southwest
RS Malhi, HM Mortensen, JA Eshleman, BM Kemp, JG Lorenz, FA Kaestle, ...
American Journal of Physical Anthropology: The Official Publication of the …, 2003
1542003
Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets
TB Knudsen, KA Houck, NS Sipes, AV Singh, RS Judson, MT Martin, ...
Toxicology 282 (1-2), 1-15, 2011
1502011
AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks
ME Pittman, SW Edwards, C Ives, HM Mortensen
Toxicology and applied pharmacology 343, 71-83, 2018
722018
Accelerating adverse outcome pathway development using publicly available data sources
NO Oki, MD Nelms, SM Bell, HM Mortensen, SW Edwards
Current environmental health reports 3, 53-63, 2016
622016
Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations
HM Mortensen, A Froment, G Lema, JM Bodo, M Ibrahim, TB Nyambo, ...
Pharmacogenomics 12 (11), 1545-1558, 2011
492011
Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century
HM Mortensen, SY Euling
Toxicology and applied pharmacology 271 (3), 395-404, 2013
332013
Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment
HM Mortensen, J Chamberlin, B Joubert, M Angrish, N Sipes, JS Lee, ...
Mammalian genome 29, 190-204, 2018
232018
Using pathway modules as targets for assay development in xenobiotic screening
RS Judson, HM Mortensen, I Shah, TB Knudsen, F Elloumi
Molecular BioSystems 8 (2), 531-542, 2012
182012
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop
LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ...
Altex 39 (2), 322–335, 2022
152022
The 2021 update of the EPA’s adverse outcome pathway database
HM Mortensen, J Senn, T Levey, P Langley, AJ Williams
Scientific Data 8 (1), 169, 2021
152021
The AOP-DB RDF: Applying FAIR principles to the semantic integration of AOP data using the research description framework
HM Mortensen, M Martens, J Senn, T Levey, CT Evelo, EL Willighagen, ...
Frontiers in Toxicology 4, 803983, 2022
82022
A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma
M Martens, F Kreidl, F Ehrhart, D Jean, M Mei, HM Mortensen, A Nash, ...
Frontiers in oncology 12, 849640, 2022
52022
An EPA database on the effects of engineered nanomaterials-NaKnowBase
WK Boyes, B Beach, G Chan, BLM Thornton, P Harten, HM Mortensen
Scientific Data 9 (1), 12, 2022
42022
Why adverse outcome pathways need to be FAIR
C Wittwehr, LA Clerbaux, S Edwards, M Angrish, H Mortensen, A Carusi, ...
ALTEX-Alternatives to animal experimentation 41 (1), 50-56, 2024
22024
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20